Capricor Therapeutics, Inc.
CAPR
$26.01
-$0.15-0.57%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -114.59M | -105.04M | -81.99M | -69.98M | -55.06M |
| Total Depreciation and Amortization | 2.02M | 1.89M | 1.76M | 1.63M | 1.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 21.46M | 21.14M | 16.28M | 13.94M | 12.45M |
| Change in Net Operating Assets | -1.52M | 12.20M | 2.91M | 1.42M | -4.04M |
| Cash from Operations | -92.63M | -69.81M | -61.04M | -52.99M | -45.16M |
| Capital Expenditure | -21.33M | -11.72M | -7.33M | -3.38M | -2.01M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -59.72M | 109.20M | -61.66M | -79.55M | -80.78M |
| Cash from Investing | -81.05M | 97.48M | -68.99M | -82.94M | -82.79M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 250.31M | 248.89M | 81.16M | 148.48M | 150.53M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 250.31M | 248.89M | 81.16M | 148.48M | 150.53M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.63M | 276.56M | -48.87M | 12.55M | 22.58M |